Invest in cardiac infrastructure to reduce disease burden

While there is no doubt that skilled doctors and cardiologists are critical for saving lives, and their impact is even greater when supported by strong healthcare infrastructure. India’s cardiac care ecosystem is evolving, yet challenges remain in ensuring widespread access to quality care—especially in rural regions, and in addressing the shortage of trained healthcare professionals and resources. Encouragingly, advancements in technology and the growing healthcare market are beginning to bridge some of these gaps. To reverse the rising tide of cardiac deaths in India, the key is to build robust, cost-effective solutions and sufficient medical professionals, institutions dedicated to heart disease treatment and management.

Timely and reliable diagnosis is often the deciding factor between life and death in cardiac emergencies. Yet, many cardiac and CVD patients in India lose valuable time during the golden hour—the crucial 60 minutes following a cardiac arrest—due to the lack of nearby diagnostic and interventional infrastructure, particularly in underserved areas. In this critical window, the heart muscles can still be saved from permanent damage, making it imperative to act swiftly with both diagnosis and treatment. Modern healthcare infrastructure must be equipped to support this urgency. Advanced imaging technologies such as CT scanners and MRIs play a vital role in assessing the severity of strokes and other cardiac conditions during this period. Additionally, point-of-care ultrasound is proving to be a powerful tool for early cardiovascular risk detection at primary care levels, enabling faster clinical decisions. However, timely diagnosis alone is not enough—effective emergency treatment must follow. This includes rapid administration of clot-busting drugs, oxygen therapy, and other life-saving interventions. A seamless transition from ambulances to hospital to advanced care is essential to maximise the benefits of timely intervention. In this context, cath labs have become increasingly significant. These specialised facilities, equipped with advanced imaging and minimally invasive technologies, are transforming both the diagnosis and treatment of heart conditions—helping deliver faster, more precise interventions and significantly improving patient outcomes.

While Tier 1 cities boast advanced cardiac infrastructure, healthcare systems in Tier 2, 3, and 4 cities are still evolving. Reports indicate that smaller cities and rural areas often lack access to advanced technologies, critical care specialists, and essential medical equipment, impacting the quality of cardiac care. Nearly 80% of the population remains underserved***. Recognising this gap, healthcare providers are investing significantly in these regions, transforming them into pivotal hubs for cardiovascular care. Continuous improvements in customer satisfaction, work culture, processes, and technologies are enhancing accessibility, efficiency, and affordability of treatment. Increased public and private sector spending, along with stronger collaborations between hospitals, governments, and tech companies, are driving positive changes, strengthening critical care infrastructure beyond metropolitan centers.

Cath labs are playing a central role in this transformation by enabling timely detection, minimally invasive interventions, and faster recovery times. The expansion of cath labs across India is not only creating milestone in cardiac care but also making it more affordable. By enabling timely detection and minimally invasive treatments like angioplasty, cath labs help reduce the need for expensive open-heart surgeries and prolonged hospital stays. Advances in technology, local manufacturing of medical equipment, and government healthcare initiatives are also helping to cut down the expenses. As a result, quality cardiac care is becoming more accessible to a wider section of the population, including patients in semi-urban and rural areas. A holistic approach that strengthens both medical expertise and diagnostic infrastructure is essential to reduce the cardiac disease burden meaningfully.

DISCLAIMER

Information, estimates, expectations and business plans in this press-release may include forward-looking statements for knowledge sharing purposes and not intended to provide medical advice, diagnosis, or treatment suggestions. All information provided by or on behalf of Philips (or any of its affiliates) is provided on an “as is, where is” basis, and no representation or warranty, express or implied, regarding the accurateness or correctness thereof is assumed by Philips in any manner. Philips shall not be liable for any damages arising from the contents including but not limited to direct, indirect, incidental, punitive and consequential damages.